Show simple item record

dc.contributor.authorSexton, Claire E
dc.contributor.authorAnstey, Kaarin J
dc.contributor.authorBaldacci, Filippo
dc.contributor.authorBarnum, CJ
dc.contributor.authorBarron, Anna M
dc.contributor.authorBlennow, Kaj
dc.contributor.authorBrodaty, Henry
dc.contributor.authorBurnham, Samantha
dc.contributor.authorElahi, Fanny M
dc.contributor.authorGötz, Jürgen
dc.contributor.authorJeon, Yun-Hee
dc.contributor.authorKoronyo-Hamaoui, Maya
dc.contributor.authorLandau, Susan M
dc.contributor.authorMoyle, Wendy
dc.contributor.authoret al.
dc.date.accessioned2021-06-07T23:57:01Z
dc.date.available2021-06-07T23:57:01Z
dc.date.issued2021
dc.identifier.issn1552-5260
dc.identifier.doi10.1002/alz.12380
dc.identifier.urihttp://hdl.handle.net/10072/404963
dc.description.abstractThe Alzheimer's Association International Conference held its sixth Satellite Symposium in Sydney, Australia in 2019, highlighting the leadership of Australian researchers in advancing the understanding of and treatment developments for Alzheimer's disease (AD) and other dementias. This leadership includes the Australian Imaging, Biomarker, and Lifestyle Flagship Study of Ageing (AIBL), which has fueled the identification and development of many biomarkers and novel therapeutics. Two multimodal lifestyle intervention studies have been launched in Australia; and Australian researchers have played leadership roles in other global studies in diverse populations. Australian researchers have also played an instrumental role in efforts to understand mechanisms underlying vascular contributions to cognitive impairment and dementia; and through the Women's Healthy Aging Project have elucidated hormonal and other factors that contribute to the increased risk of AD in women. Alleviating the behavioral and psychological symptoms of dementia has also been a strong research and clinical focus in Australia.
dc.description.peerreviewedYes
dc.languageeng
dc.publisherWiley
dc.relation.ispartofjournalAlzheimer's & Dementia
dc.subject.fieldofresearchClinical Sciences
dc.subject.fieldofresearchNeurosciences
dc.subject.fieldofresearchcode1103
dc.subject.fieldofresearchcode1109
dc.subject.keywordsAlzheimer's
dc.subject.keywordsbehavioral symptoms
dc.subject.keywordsbiomarkers
dc.subject.keywordsdementia
dc.subject.keywordsprevention
dc.titleAlzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationSexton, CE; Anstey, KJ; Baldacci, F; Barnum, CJ; Barron, AM; Blennow, K; Brodaty, H; Burnham, S; Elahi, FM; Götz, J; Jeon, Y-H; Koronyo-Hamaoui, M; Landau, SM; Moyle, W; et al., Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney, Alzheimer's & Dementia, 2021
dcterms.dateAccepted2021-04-20
dc.date.updated2021-06-07T23:43:48Z
dc.description.versionVersion of Record (VoR)
gro.rights.copyright© 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
gro.hasfulltextFull Text
gro.griffith.authorMoyle, Wendy


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record